Laure Ory-Lavollée
Career history of Laure Ory-Lavollée
Former positions of Laure Ory-Lavollée
| Companies | Position | Start | End |
|---|---|---|---|
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Director/Board Member | - | 2009-09-14 |
| Puilaetco | Analyst-Equity | 2002-05-14 | 2002-05-14 |
| CELLECTIS S.A. | Director/Board Member | - | - |
Statistics
International
| France | 3 |
| 2 |
Operational
| Director/Board Member | 2 |
| Analyst-Equity | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Private companies | 2 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
| Puilaetco | Finance |
- Stock Market
- Insiders
- Laure Ory-Lavollée
- Experience
